515 related articles for article (PubMed ID: 12452205)
1. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Berges-Gimeno MP; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
[TBL] [Abstract][Full Text] [Related]
2. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
3. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
[TBL] [Abstract][Full Text] [Related]
5. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.
Dursun AB; Woessner KA; Simon RA; Karasoy D; Stevenson DD
Ann Allergy Asthma Immunol; 2008 May; 100(5):420-5. PubMed ID: 18517072
[TBL] [Abstract][Full Text] [Related]
6. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
Woessner KM; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
[TBL] [Abstract][Full Text] [Related]
7. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
Williams AN; Simon RA; Woessner KM; Stevenson DD
J Allergy Clin Immunol; 2007 Aug; 120(2):273-7. PubMed ID: 17481713
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
Williams AN
Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
[TBL] [Abstract][Full Text] [Related]
10. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
[TBL] [Abstract][Full Text] [Related]
11. The safety of celecoxib in patients with aspirin-sensitive asthma.
Woessner KM; Simon RA; Stevenson DD
Arthritis Rheum; 2002 Aug; 46(8):2201-6. PubMed ID: 12209526
[TBL] [Abstract][Full Text] [Related]
12. Natural history and clinical features of aspirin-exacerbated respiratory disease.
Fahrenholz JM
Clin Rev Allergy Immunol; 2003 Apr; 24(2):113-24. PubMed ID: 12668892
[TBL] [Abstract][Full Text] [Related]
13. [Nasal polyps is not a homogenous pathology].
Arcimowicz M; Balcerzak J; Samoliński BK
Pol Merkur Lekarski; 2005 Sep; 19(111):276-9. PubMed ID: 16358841
[TBL] [Abstract][Full Text] [Related]
14. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
Mullol J; Picado C
Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
[TBL] [Abstract][Full Text] [Related]
15. Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study.
Sommer DD; Hoffbauer S; Au M; Sowerby LJ; Gupta MK; Nayan S
Otolaryngol Head Neck Surg; 2015 Jan; 152(1):42-7. PubMed ID: 25344589
[TBL] [Abstract][Full Text] [Related]
16. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
17. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
Pfaar O; Klimek L
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
[TBL] [Abstract][Full Text] [Related]
18. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity to nonsteroidal anti-inflammatory drugs.
Namazy JA; Simon RA
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):542-50; quiz 550, 605. PubMed ID: 12487218
[TBL] [Abstract][Full Text] [Related]
20. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease.
Berges-Gimeno MP; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2003 Mar; 90(3):338-41. PubMed ID: 12669898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]